TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 4.581 million compared to TWD 4.799 million a year ago. Operating loss was TWD 88.397 million compared to TWD 66.904 million a year ago. Net loss was TWD 99.437 million compared to TWD 102.750 million a year ago. Basic loss per share was TWD 0.14 compared to TWD 0.14 a year ago. For the nine months, sales was TWD 15.400 million compared to TWD 13.497 million a year ago. Operating loss was TWD 201.341 million compared to TWD 193.391 million a year ago. Net loss was TWD 274.550 million compared to TWD 96.375 million a year ago. Basic loss per share was TWD 0.38 compared to TWD 0.13 a year ago.